Clinical Trials in New York State

Showing 4881-4900 of 13,041 trials

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

NCT05660577

The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis

Myopia and Hyperopia and Presbyopia

Bausch & Lomb Incorporated301 participantsStarted Nov 2022

San Diego, California, United States • San Francisco, California, United States • Denver, Colorado, United States +17 more locations

COMPLETEDPhase 379 miles

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

NCT04599972

This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.

Presbyopia

Orasis Pharmaceuticals Ltd.304 participantsStarted Oct 2020

Chandler, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +15 more locations

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

Find Trials by Condition in New York State

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry

Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)

Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection